Other than chronic granulomatous disease, IFN-γ immunotherapy is often used to treat cancer, tuberculosis, cystic fibrosis, hepatitis, osteoporosis, scleroderma, and invasive fungal infection. Here, IFNG is linked to chronic granulomatous disease.